Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Federal Trade Commission
Harvard Business School
Teva
McKesson
Cerilliant
UBS
Fuji
Julphar
Cipla

Generated: January 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019643

« Back to Dashboard

NDA 019643 describes MEVACOR, which is a drug marketed by Merck and is included in one NDA. Additional details are available on the MEVACOR profile page.

The generic ingredient in MEVACOR is lovastatin. There are thirty-three drug master file entries for this compound. Forty-three suppliers are listed for this compound. Additional details are available on the lovastatin profile page.
Summary for 019643
Tradename:MEVACOR
Applicant:Merck
Ingredient:lovastatin
Patents:0
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 019643

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength10MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Mar 28, 1991TE:RLD:Yes

Profile for product number 003

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength20MG **Federal Register notice that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Aug 31, 1987TE:RLD:Yes

Profile for product number 004

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength40MG **Federal Register notice that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Dec 14, 1988TE:RLD:Yes

Expired US Patents for NDA 019643

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Merck MEVACOR lovastatin TABLET;ORAL 019643-002 Mar 28, 1991 ➤ Subscribe ➤ Subscribe
Merck MEVACOR lovastatin TABLET;ORAL 019643-003 Aug 31, 1987 ➤ Subscribe ➤ Subscribe
Merck MEVACOR lovastatin TABLET;ORAL 019643-004 Dec 14, 1988 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Citi
Dow
Moodys
Express Scripts
Novartis
Deloitte
Cipla
Covington
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot